|
Wednesday, November 15, 2023
Print Current Session:
 |
|
|
Wednesday
SESSION 38:
UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; VASCULAR REGISTRIES AND THE VQI, VALUE OF GUIDELINES AND RCTs: THE FDA: STATISTICS; EVIDENCE BASED MEDICINE; MISCELLANEOUS
|
|
| SESSION 38 SCHEDULE | |
| 4:57 PM - 5:02 PM | What Obstacles And Blows Are Vascular Surgeons And Other Vascular Specialists Facing In 2023: Will Planned Increased Reimbursement For Office And Hospital Visits Cause More Decreases In Procedural Reimbursements |
|
Presenter(s):Sean P. Roddy, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:03 PM - 5:08 PM | VQI Collaboration With The International Consortium of Vascular Registries (ICVR): How Can It Better Evaluate Aortic Endograft Performance |
|
Presenter(s):Adam Beck, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:09 PM - 5:14 PM Power Point Presentation with Synched Audio |
The Role And Value Of Guidelines And RCTs In Vascular Practice; Why Guidelines And RCTs Can Be Misleading: What To Do About The Problem |
|
Presenter(s):Anders Wanhainen, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| REGULATORY AND FDA ISSUES | |
| 5:15 PM - 5:20 PM | How Can A Device Qualify With The FDA For BREAKTHROUGH Status And How Does It Differ From SAFER Status |
|
Presenter(s):Valerie M. Merkle, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:21 PM - 5:26 PM | Past, Present And Future Collaboration Between Industry, Clinicians And The FDA To Address Unmet Clinical Needs: We Should Not Be Adversaries |
|
Presenter(s):Dorothy B. Abel, BSBME Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| EVIDENCE-BASED MEDICINE ISSUES | |
| 5:27 PM - 5:32 PM | Improved And Simplified Clinical Trial Statistics For Dummies: Why p Values Are Decreasing In Importance And Bayesian Statistics Are Increasing In Importance: What Is The Latter |
|
Presenter(s):Charles C. Miller, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:33 PM - 5:38 PM | Registry Based RCTs (RBRCTs): What Are They, How Do They Work And Why Are They Better Than Other Evidence-Based Techniques |
|
Presenter(s):Jens Eldrup-Jorgensen, MD / Jack L. Cronenwett, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:39 PM - 5:44 PM | Panel Discussion |
| MISCELLANEOUS | |
| 5:45 PM - 5:50 PM | Managing Various Specialties And Generations Of Specialists In A Multi-Specialty Vascular Institute Or Center: How To Satisfy Everyone And Optimize Patient Outcomes |
|
Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:51 PM - 5:56 PM | Despite What The New York Times And Others Say, Close Relationships Of Vascular Surgeons With Industry Are Mostly Ethical And Beneficial To Patients And Society: Pitfalls To Avoid |
|
Presenter(s):Bruce A. Perler, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 5:57 PM - 6:02 PM | Innovation In Vascular Surgery: Ideas, Funding, Partners And Intellectual Property: How To Turn Fantasy Into Reality |
|
Presenter(s):Jeffrey H. Lawson, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:03 PM - 6:08 PM | Current Quality Analysis For Vascular Surgeons And Vascular Specialists Does Not Reflect Quality Of Care: Why And What Can Be Done About It |
|
Presenter(s):Richard F. Neville, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:09 PM - 6:14 PM | Editorial Update On The JVS And All Its Progeny: Its Status And How It Will Be Improved |
|
Presenter(s):Ronald L. Dalman, MD / Thomas L. Forbes, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:15 PM - 6:20 PM | Effects Of The Affordable Care Act (ACA) On Vascular Surgical Outcomes: Does The Medicaid Expansion Of The ACA Improve Outcomes Or Not |
|
Presenter(s):Mohammad H. Eslami, MD, MPH Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:21 PM - 6:30 PM | Panel Discussion End of Program E |
| END OF SESSION 38 | |
| previous | next |